Tyme Technologies Inc (NASDAQ:TYME)

0.309
BATS BZX Real-Time Price
As of 12:47pm ET
 +0.0425 / +15.95%
Today’s Change
0.22
Today|||52-Week Range
2.02
-48.76%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Major
MARKET CAP
$45.3M

Company Description

Tyme Technologies, Inc. operates as a biotechnology company, which engages in the development and commercialization of cancer therapies. It offers a clinical program named SM-88 which is a novel, oral, and monotherapy investigational agent that aims to disrupt the cancer cell's protein synthesis. The company was founded by Steve Hoffman and Michael Demurjian on November 22, 2011 and is headquartered in Bedminster, NJ.

Contact Information

Tyme Technologies, Inc.
1 Pluckemin Way
Bedminster New Jersey 07921
P:(212) 461-2315
Investor Relations:
(212) 452-2793

Employees

Shareholders

Other institutional5.55%
Individual stakeholders31.13%
Mutual fund holders3.02%

Top Executives

Richard Anthony CunninghamChief Executive Officer & Director
Frank L. PorfidoChief Financial Officer
Jan M. van TornoutChief Medical Officer
Jonathan M. EckardChief Business Officer
John M. RothmanExecutive Vice President-Product Development